alprazolam has been researched along with clonazepam in 80 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (17.50) | 18.7374 |
| 1990's | 30 (37.50) | 18.2507 |
| 2000's | 12 (15.00) | 29.6817 |
| 2010's | 15 (18.75) | 24.3611 |
| 2020's | 9 (11.25) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abdelkafi, H; Ait Ouarab, L; Barbier, J; Buisson, DA; Caramelle, L; Cintrat, JC; Clerget, A; Gillet, D; Michau, A; Montoir, D; Ngadjeua, F; Pons, V | 1 |
| Cotreau, MM; Greenblatt, DJ; Harmatz, JS; Horst, WD; Preskorn, SH | 1 |
| Miller, LG | 1 |
| al-Tikriti, MS; Baldwin, RM; Innis, RB; Johnson, EW; Laruelle, MA; Malison, RT; Seibyl, JP; Sybirska, EH; Zimmermann, RC; Zoghbi, SS | 1 |
| DeVane, CL; Lydiard, RB; Ware, MR | 1 |
| Bertorini, TE; Lemmi, H; Silva, AB | 1 |
| Pollack, MH | 1 |
| Tesar, GE | 1 |
| Bodkin, JA | 1 |
| Krsiak, M; Sulcova, A | 1 |
| Cohen, LS; Herman, JB; Otto, MW; Pollack, MH; Rosenbaum, JF; Sachs, GS; Spier, SA; Tesar, GE | 1 |
| Altamura, AC; Mauri, MC; Percudani, M; Regazzetti, MG | 1 |
| Asher, R; Meltzer-Brody, S; O'Neil, C; Otto, MW; Pollack, MH; Rosenbaum, JF; Sachs, GS | 1 |
| Davidson, JR | 2 |
| Rosenbaum, JF | 1 |
| Patterson, JF | 2 |
| Cohen, LS; Fava, M; Hirsch, M; MacLaughlin, RA; Pollack, MH; Rosenbaum, JF; Tesar, GE | 1 |
| Gastfriend, DR; Rosenbaum, JF | 1 |
| Greenblatt, DJ; Lopez, F; Miller, LG; Paul, SM; Shader, RI | 1 |
| Clow, A; Glover, V; Sandler, M | 1 |
| Brotman, AW; Herman, JB; Rosenbaum, JF | 2 |
| Albeck, JH | 1 |
| Beckett, A; Fishman, SM; Rosenbaum, JF | 1 |
| Herman, JB; Pollack, MH; Rosenbaum, JF; Sachs, GS; Tesar, GE | 1 |
| Cohen, LS; Goldstein, S; Herman, JB; Mahoney, EM; McNamara, M; Pollack, MH; Rosenbaum, JF; Sachs, GS; Tesar, GE | 1 |
| Rosenbaum, JF; Spier, SA; Tesar, GE; Woods, SW | 1 |
| Rosenbaum, JF; Tesar, GE | 1 |
| Annable, L; Chouinard, G; Fontaine, R; Labonte, A | 1 |
| Jenck, F; Martin, JR; Moreau, JL | 1 |
| Needleman, SB; Porvaznik, M | 1 |
| Labbate, LA; Otto, MW; Pollack, MH; Rosenbaum, JF; Tesar, GM | 1 |
| Hammerness, PG; Kaspi, SP; Otto, MW; Pollack, MH; Rosenbaum, JF | 1 |
| Davidson, JR; Potts, NL; Tupler, LA | 1 |
| Cohen, LS; Meltzer-Brody, S; Otto, MW; Pollack, MH; Rosenbaum, JF; Tesar, GE | 1 |
| Meltzer-Brody, S; Otto, MW; Pollack, MH; Reiter, SR; Rosenbaum, JF; Sachs, GS | 1 |
| Mahowald, MW; Schenck, CH | 1 |
| Akerman, KK; Jolkkonen, J; Parviainen, M; Penttilä, I | 1 |
| Hetem, LA | 1 |
| Mazurek, MF; Rosebush, PI | 1 |
| Freeman, S | 1 |
| Feiner, NF | 1 |
| Bonne, O; Brandes, D; Gelpin, E; Peri, T; Shalev, AY | 1 |
| Brewster, S; Murray, M; Rothschild, AJ; Shindul-Rothschild, JA; Viguera, A | 1 |
| Jefferson, JW | 1 |
| Czeizel, AE; Eros, E; Olsen, J; Rockenbauer, M; Sorensen, HT | 1 |
| Bogojevic, G; Kelin, K; Kolar, D; Latas, M; Starcevic, V | 1 |
| Choi, YH; Lee, JH; Park, KH; Riva, G; Vincelli, F; Wiederhold, BK | 1 |
| Dickson, SJ; Irving, RC | 1 |
| Cai, ZJ; He, JL; Li, WB; Ungvari, GS; Xiang, YT | 1 |
| Kulvanich, P; Ongpipattanakul, B; Sila-on, W; Vardhanabhuti, N | 1 |
| Tóth, AR; Varga, T | 1 |
| Marin, SJ; McMillin, GA | 1 |
| Gunn, J; Kriger, S; Terrell, AR | 1 |
| Arroyo Plasencia, AM; Ballentine, LM; Kao, LW; Mowry, JB | 1 |
| Farach, FJ; McHugh, RK; Otto, MW; Pollack, MH; Simon, NM; Worthington, JJ | 1 |
| Butman, ML; Henry, ME; Jensen, JE; Lauriat, TL; Licata, SC; Ravichandran, C; Renshaw, PF; Shanahan, M | 1 |
| Abrahamowicz, M; Čapek, R; Sylvestre, MP; Tamblyn, R | 1 |
| Mullins, ME; Rengarajan, A | 1 |
| Krzek, J; Maślanka, A; Szlósarczyk, M; Wach, K; Żmudzki, P | 1 |
| Christophersen, AS; Enger, A; Nordal, K; Vindenes, V; Øiestad, EL | 1 |
| Gong, L; Guo, C; Jiang, S; Shi, F; Tan, H | 1 |
| Dang, H; Kaufman, DL; Middleton, B; Tian, J | 1 |
| Fiorentin, TR; Logan, BK | 1 |
| Concheiro, M; Cruz, A; de-Castro-Ríos, A; Lendoiro, E; López-Rabuñal, A; López-Rivadulla, M | 1 |
| Falcon, M; Fernadez-Lopez, L; Luna, A; Mancini, R; Pellegrini, M; Rotolo, M | 1 |
| Alejandro Serra, H; Morozov, M; Nuske, EO | 1 |
| Coulter, C; Garnier, M; Moore, C | 1 |
| Acton, EK; Bilker, WB; Brensinger, CM; Chen, C; Chung, SP; Dawwas, GK; Hennessy, S; Horn, JR; Leonard, CE; Miano, TA; Pham Nguyen, TP | 1 |
| Adhikari, S; Barron, LP; Bhatnagar, A; Bowes, DA; Coronado-Apodaca, KG; Driver, EM; Halden, RU; Kumar, R; Martínez-Ruiz, M; McCall, KL; Melchor-Martínez, EM; Ng, KT; Oyervides-Muñoz, MA; Parra-Saldivar, R; Piper, BJ; Smith, T; Sosa-Hernandez, JE | 1 |
| Buratti, E; Cerioni, A; Cingolani, M; Cippitelli, M; Froldi, R; Mietti, G; Scendoni, R | 1 |
| Barbui, C; Bighelli, I; Caldwell, DM; Cipriani, A; Davies, SJ; Dawson, S; Dias, S; Furukawa, TA; Guaiana, G; Imai, H; Koesters, M; Meader, N; Pompoli, A; Robertson, L; Tajika, A | 1 |
14 review(s) available for alprazolam and clonazepam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Chronic benzodiazepine administration: from the patient to the gene.
Topics: Alprazolam; Animals; Benzodiazepines; Clonazepam; Down-Regulation; Drug Tolerance; Flumazenil; Humans; Lorazepam; Mice; Receptors, GABA-A; RNA, Messenger; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors; Up-Regulation | 1991 |
Pharmacokinetics, pharmacodynamics, and treatment issues of benzodiazepines: alprazolam, adinazolam, and clonazepam.
Topics: Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Clonazepam; Humans | 1991 |
Long-term management of panic disorder.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Drug Tolerance; Fear; Follow-Up Studies; Humans; Panic | 1990 |
High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Fear; Humans; Outcome and Process Assessment, Health Care; Panic; Placebos | 1990 |
Emerging uses for high-potency benzodiazepines in psychotic disorders.
Topics: Alprazolam; Anti-Anxiety Agents; Catatonia; Child; Clinical Trials as Topic; Clonazepam; Female; Humans; Male; Psychomotor Agitation; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1990 |
Alternative prophylactic treatments to lithium in bipolar disorders.
Topics: Alprazolam; Bipolar Disorder; Calcium Channel Blockers; Carbamazepine; Clonazepam; Humans; Lithium; Valproic Acid | 1990 |
Continuation treatment of panic disorder with high-potency benzodiazepines.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Behavior Therapy; Benzodiazepines; Clonazepam; Humans; Panic | 1990 |
Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines.
Topics: Acute Disease; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clonazepam; Fear; Female; Humans; Male; Panic; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome | 1987 |
Withdrawal and detoxification from benzodiazepine dependence: a potential role for clonazepam.
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Clonazepam; Diazepam; Drug Tolerance; Humans; Male; Middle Aged; Substance Withdrawal Syndrome; Substance-Related Disorders; Triazolam | 1987 |
Treatment of social phobia with benzodiazepines.
Topics: Alprazolam; Benzodiazepines; Clinical Trials as Topic; Clonazepam; Double-Blind Method; Humans; Phobic Disorders; Pilot Projects; Placebos; Psychiatric Status Rating Scales; Recurrence; Treatment Outcome | 1994 |
Use of benzodiazepines in panic disorder.
Topics: Alprazolam; Benzodiazepines; Clonazepam; Humans; Lorazepam; Panic Disorder; Treatment Outcome | 1997 |
The use of GA-RxODE (Genetics Algorithms and Running simulations from Ordinary Differential Equations-based model) method to optimize bioequivalence studies.
Topics: Algorithms; Alprazolam; Anti-Anxiety Agents; Clonazepam; Computer Simulation; Drugs, Generic; Humans; Hypoglycemic Agents; Metformin; Pharmacokinetics; Therapeutic Equivalency | 2021 |
Pharmacological treatments in panic disorder in adults: a network meta-analysis.
Topics: Adult; Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzodiazepines; Clomipramine; Clonazepam; Desipramine; Diazepam; Fluoxetine; Humans; Network Meta-Analysis; Panic Disorder; Paroxetine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride | 2023 |
17 trial(s) available for alprazolam and clonazepam
| Article | Year |
|---|---|
Fluoxetine impairs clearance of alprazolam but not of clonazepam.
Topics: Adolescent; Adult; Alprazolam; Analysis of Variance; Clonazepam; Double-Blind Method; Drug Interactions; Fluoxetine; Half-Life; Humans; Male; Reference Values | 1992 |
Long-term management of panic disorder.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Drug Tolerance; Fear; Follow-Up Studies; Humans; Panic | 1990 |
High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Fear; Humans; Outcome and Process Assessment, Health Care; Panic; Placebos | 1990 |
Emerging uses for high-potency benzodiazepines in psychotic disorders.
Topics: Alprazolam; Anti-Anxiety Agents; Catatonia; Child; Clinical Trials as Topic; Clonazepam; Female; Humans; Male; Psychomotor Agitation; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1990 |
Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Ataxia; Clonazepam; Double-Blind Method; Female; Humans; Male; Outcome and Process Assessment, Health Care; Panic; Patient Dropouts; Personality Inventory; Placebos; Psychiatric Status Rating Scales; Sleep | 1991 |
Dehydroepiandrosterone-sulfate/cortisol ratio in panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Clinical Trials as Topic; Clonazepam; Dehydroepiandrosterone; Double-Blind Method; Fear; Female; Humans; Hydrocortisone; Male; Panic; Phobic Disorders; Random Allocation | 1989 |
Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Double-Blind Method; Fear; Humans; Middle Aged; Outcome and Process Assessment, Health Care; Panic; Prospective Studies; Psychiatric Status Rating Scales; Random Allocation | 1987 |
New concepts in benzodiazepine therapy: rebound anxiety and new indications for the more potent benzodiazepines.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Bromazepam; Clinical Trials as Topic; Clonazepam; Diazepam; Humans; Panic; Receptors, Cell Surface; Receptors, GABA-A; Recurrence; Substance Withdrawal Syndrome | 1983 |
The relationship of alprazolam and clonazepam dose to steady-state concentration in plasma.
Topics: Adolescent; Adult; Alprazolam; Clonazepam; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Panic Disorder | 1994 |
Cognitive behavior therapy for treatment-refractory panic disorder.
Topics: Adult; Alprazolam; Clonazepam; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Fluoxetine; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Panic Disorder; Pilot Projects; Psychiatric Status Rating Scales; Psychotherapy, Group; Treatment Outcome | 1994 |
Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder.
Topics: Adult; Alprazolam; Clonazepam; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Panic Disorder; Prognosis; Psychiatric Status Rating Scales; Time Factors | 1993 |
Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder.
Topics: Adult; Alprazolam; Ambulatory Care; Benzodiazepines; Clonazepam; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Panic Disorder; Substance Withdrawal Syndrome; Treatment Outcome | 1993 |
Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Chronic Disease; Clonazepam; Drug Administration Schedule; Female; Humans; Male; Polysomnography; Restless Legs Syndrome; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Somnambulism; Substance-Related Disorders; Treatment Outcome | 1996 |
Treatment of recent trauma survivors with benzodiazepines: a prospective study.
Topics: Alprazolam; Anxiety Disorders; Arousal; Benzodiazepines; Clonazepam; Follow-Up Studies; Heart Rate; Humans; Life Change Events; Personality Inventory; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Stress Disorders, Post-Traumatic; Survivors; Treatment Outcome | 1996 |
Effects of group experiential cognitive therapy for the treatment of panic disorder with agoraphobia.
Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anticonvulsants; Clonazepam; Cognitive Behavioral Therapy; Demography; Female; Humans; Male; Panic Disorder; Psychotherapy, Brief; Psychotherapy, Group; Surveys and Questionnaires | 2005 |
Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation.
Topics: Adult; Alprazolam; Benzodiazepines; Clonazepam; Cognitive Behavioral Therapy; Dose-Response Relationship, Drug; Fear; Female; Humans; Male; Panic Disorder; Relaxation Therapy; Secondary Prevention; Substance Withdrawal Syndrome | 2010 |
The acute and late CNS glutamine response to benzodiazepine challenge: a pilot pharmacokinetic study using proton magnetic resonance spectroscopy.
Topics: Adult; Alprazolam; Aspartic Acid; Benzodiazepines; Brain Mapping; Central Nervous System; Choline; Clonazepam; Creatine; Cross-Over Studies; Double-Blind Method; GABA Modulators; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Hypnotics and Sedatives; Magnetic Resonance Spectroscopy; Male; Pilot Projects; Protons; Time Factors; Young Adult | 2010 |
52 other study(ies) available for alprazolam and clonazepam
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Structure-Activity Relationship Studies of Retro-1 Analogues against Shiga Toxin.
Topics: Benzodiazepinones; Golgi Apparatus; HeLa Cells; Humans; Protein Transport; Shiga Toxins; Structure-Activity Relationship | 2020 |
SPECT imaging of the benzodiazepine receptor: feasibility of in vivo potency measurements from stepwise displacement curves.
Topics: Alprazolam; Animals; Benzodiazepines; Brain; Brain Chemistry; Clonazepam; Diazepam; Female; Flumazenil; Injections, Intravenous; Macaca mulatta; Male; Papio; Receptors, GABA-A; Tomography, Emission-Computed, Single-Photon | 1991 |
Polysomnography in idiopathic muscle pain syndrome (fibrositis).
Topics: Alprazolam; Amitriptyline; Clonazepam; Electroencephalography; Fatigue Syndrome, Chronic; Female; Fibromyalgia; Humans; Male; Monitoring, Physiologic; Sensory Thresholds; Sleep Wake Disorders | 1991 |
Differential effects of six structurally related benzodiazepines on some ethological measures of timidity, aggression and locomotion in mice.
Topics: Aggression; Alprazolam; Animals; Anti-Anxiety Agents; Behavior, Animal; Clonazepam; Lorazepam; Male; Mice; Motor Activity; Nitrazepam; Oxazepam; Shyness; Structure-Activity Relationship; Triazolam | 1990 |
Longitudinal course of panic disorder: findings from the Massachusetts General Hospital Naturalistic Study.
Topics: Alprazolam; Anxiety Disorders; Child, Preschool; Chronic Disease; Clonazepam; Cognitive Behavioral Therapy; Depressive Disorder; Disease Susceptibility; Humans; Longitudinal Studies; Panic; Personality Disorders; Phobic Disorders; Psychiatric Status Rating Scales; Psychotropic Drugs | 1990 |
Switching patients from alprazolam to clonazepam.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Clonazepam; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Panic; Substance Withdrawal Syndrome; Substance-Related Disorders | 1990 |
Withdrawal from alprazolam dependency using clonazepam: clinical observations.
Topics: Alprazolam; Ambulatory Care; Clonazepam; Hospitalization; Humans; Male; Middle Aged; Stress Disorders, Post-Traumatic; Substance Withdrawal Syndrome; Substance-Related Disorders | 1990 |
Adjunctive buspirone in benzodiazepine treatment of four patients with panic disorder.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety; Buspirone; Clonazepam; Diazepam; Drug Combinations; Fear; Female; Humans; Male; Middle Aged; Panic; Phobic Disorders | 1989 |
Low-dose alprazolam augments motor activity in mice.
Topics: Alprazolam; Animals; Clonazepam; Exploratory Behavior; Flumazenil; Male; Mice; Mice, Inbred Strains; Motor Activity; Receptors, GABA-A; Triazolam | 1988 |
Triazolam, an anomalous benzodiazepine receptor ligand: in vitro characterization of alprazolam and triazolam binding.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Carbolines; Clonazepam; Flunitrazepam; gamma-Aminobutyric Acid; Humans; Kinetics; Male; Rats; Rats, Inbred Strains; Receptors, GABA-A; Triazolam | 1985 |
Clonazepam blockade of spontaneous and CO2 inhalation-provoked panic in a patient with panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Carbon Dioxide; Clonazepam; Fear; Female; Humans; Panic | 1986 |
Clonazepam in the treatment of panic disorder and agoraphobia.
Topics: Adult; Aged; Agoraphobia; Alprazolam; Carbon Dioxide; Clonazepam; Fear; Female; Humans; Male; Middle Aged; Panic; Phobic Disorders | 1987 |
Alprazolam dependency: use of clonazepam for withdrawal.
Topics: Adult; Alprazolam; Anxiety Disorders; Clonazepam; Humans; Hydrocortisone; Male; Substance Withdrawal Syndrome | 1988 |
The alprazolam to clonazepam switch for the treatment of panic disorder.
Topics: Alprazolam; Anxiety Disorders; Clonazepam; Fear; Humans; Panic | 1987 |
Treatment of panic disorder and agoraphobia with clonazepam.
Topics: Adolescent; Adult; Aged; Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Clonazepam; Fear; Female; Humans; Male; Middle Aged; Panic; Phobic Disorders; Psychiatric Status Rating Scales; Retrospective Studies | 1986 |
Successful use of clonazepam in patients with treatment-resistant panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Clonazepam; Desipramine; Fear; Female; Humans; Imipramine; Male; Middle Aged; Panic; Phenelzine; Propranolol; Psychiatric Status Rating Scales | 1986 |
Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: elements of face and predictive validity.
Topics: Alkaloids; Alprazolam; Animals; Anti-Anxiety Agents; Brain; Caffeine; Clonazepam; Conditioning, Operant; Male; Peripheral Nervous System; Placebos; Rats; Rats, Wistar; Stereotaxic Techniques; Yohimbine | 1995 |
Identification of parent benzodiazepines by gas chromotography/mass spectroscopy (GC/MS) from urinary extracts treated with B-glucuronidase.
Topics: Alprazolam; Benzodiazepines; Chlordiazepoxide; Clonazepam; Diazepam; Gas Chromatography-Mass Spectrometry; Glucuronidase; Humans; Lorazepam; Oxazepam; Triazolam | 1995 |
Analysis of low-dose benzodiazepines by HPLC with automated solid-phase extraction.
Topics: Alprazolam; Antidepressive Agents; Automation; Benzodiazepines; Chromatography, High Pressure Liquid; Clonazepam; Humans; Nitrazepam; Phenothiazines; Sensitivity and Specificity | 1996 |
Addition of d-fenfluramine to benzodiazepines produces a marked improvement in refractory panic disorder--a case report.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Clonazepam; Drug Resistance; Female; Fenfluramine; Humans; Panic Disorder; Selective Serotonin Reuptake Inhibitors | 1996 |
Catatonia after benzodiazepine withdrawal.
Topics: Aged; Aged, 80 and over; Alprazolam; Anti-Anxiety Agents; Catatonia; Clonazepam; Diazepam; Female; Humans; Male; Middle Aged; Substance Withdrawal Syndrome | 1996 |
The realities of clonazepam discontinuation.
Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Clonazepam; Drug Administration Schedule; GABA Modulators; Half-Life; Humans; Mental Disorders; Patient Compliance; Seizures; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome | 1997 |
Antiepileptic drug augmentation for treatment-resistant depression.
Topics: Alprazolam; Anticonvulsants; Antidepressive Agents; Clonazepam; Comorbidity; Depressive Disorder; Diagnosis, Differential; Drug Therapy, Combination; Epilepsy; Epilepsy, Complex Partial; Humans | 1997 |
Comparison of the frequency of behavioral disinhibition on alprazolam, clonazepam, or no benzodiazepine in hospitalized psychiatric patients.
Topics: Adolescent; Adult; Aged; Alprazolam; Analysis of Variance; Anti-Anxiety Agents; Behavioral Symptoms; Clonazepam; Female; Hospitalization; Humans; Male; Mental Disorders; Middle Aged; Retrospective Studies | 2000 |
Benzodiazepines and anticonvulsants for social phobia (social anxiety disorder).
Topics: Acetates; Alprazolam; Amines; Anticonvulsants; Benzodiazepines; Clinical Trials as Topic; Clonazepam; Cyclohexanecarboxylic Acids; Follow-Up Studies; Gabapentin; gamma-Aminobutyric Acid; Humans; Phobic Disorders; Placebos; Pregabalin; Treatment Outcome; Valproic Acid | 2001 |
A population-based case-control teratologic study of nitrazepam, medazepam, tofisopam, alprazolum and clonazepam treatment during pregnancy.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adult; Alprazolam; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Case-Control Studies; Clonazepam; Female; Humans; Hungary; Infant, Newborn; Medazepam; Nitrazepam; Pregnancy; Pregnancy Complications; Teratogens | 2002 |
Panic disorder patients at the time of air strikes.
Topics: Adult; Agoraphobia; Aircraft; Alprazolam; Catchment Area, Health; Clonazepam; Female; Follow-Up Studies; GABA Modulators; Humans; Male; Panic Disorder; Stress, Psychological; Warfare; Yugoslavia | 2002 |
The detection of sedatives in hair and nail samples using tandem LC-MS-MS.
Topics: Adult; Aged; Aged, 80 and over; Alprazolam; Azabicyclo Compounds; Benzodiazepines; Chromatography, Liquid; Clobazam; Clonazepam; Diazepam; Female; Forensic Pathology; Hair; Humans; Hypnotics and Sedatives; Male; Mass Spectrometry; Midazolam; Middle Aged; Nails; Oxazepam; Piperazines; Predictive Value of Tests; Rape; Temazepam; Triazolam | 2007 |
Hemoperfusion in the treatment of acute clozapine intoxication in China.
Topics: Acute Disease; Adult; Alprazolam; Antipsychotic Agents; China; Clonazepam; Clozapine; Depressive Disorder; Dose-Response Relationship, Drug; Drug Overdose; Emergency Service, Hospital; Hemoperfusion; Humans; Medical History Taking; Middle Aged; Pulmonary Edema; Retrospective Studies; Schizophrenia; Stress Disorders, Post-Traumatic; Suicide, Attempted; Sulpiride; Unconsciousness; Wine | 2007 |
Influence of incorporation methods on partitioning behavior of lipophilic drugs into various phases of a parenteral lipid emulsion.
Topics: Alprazolam; Benzodiazepines; Chemistry, Pharmaceutical; Clonazepam; Diazepam; Drug Carriers; Drug Compounding; Fat Emulsions, Intravenous; Hydrogen-Ion Concentration; Lorazepam; Molecular Structure; Particle Size; Phospholipids; Solubility; Soybean Oil; Technology, Pharmaceutical; Ultracentrifugation | 2008 |
Myocardium and striated muscle damage caused by licit or illicit drugs.
Topics: Adolescent; Adult; Alprazolam; Anticonvulsants; Brain Edema; Clonazepam; Creatine Kinase; Female; Fever; Forensic Pathology; Forensic Toxicology; Hallucinogens; Hemorrhage; Humans; Hypnotics and Sedatives; Illicit Drugs; Kidney; Male; Middle Aged; Muscle, Skeletal; Muscle, Striated; Myocardium; N-Methyl-3,4-methylenedioxyamphetamine; Necrosis; Pulmonary Edema; Rhabdomyolysis; Thymus Hyperplasia | 2009 |
LC-MS/MS analysis of 13 benzodiazepines and metabolites in urine, serum, plasma, and meconium.
Topics: Alprazolam; Benzodiazepines; Chromatography, Liquid; Clonazepam; Flurazepam; Humans; Infant, Newborn; Meconium; Nordazepam; Oxazepam; Reproducibility of Results; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Triazolam | 2010 |
Simultaneous determination and quantification of 12 benzodiazepines in serum or whole blood using UPLC/MS/MS.
Topics: Alprazolam; Benzodiazepines; Chlordiazepoxide; Chromatography, Liquid; Clonazepam; Flunitrazepam; Humans; Lorazepam; Midazolam; Nordazepam; Oxazepam; Reproducibility of Results; Tandem Mass Spectrometry | 2010 |
Benzodiazepine-associated atrioventricular block.
Topics: Acetaminophen; Alprazolam; Anti-Anxiety Agents; Anticonvulsants; Antidotes; Atrioventricular Block; Child, Preschool; Clonazepam; Drug Combinations; Electrocardiography; Flumazenil; Humans; Hydrocodone; Male; Risperidone; Young Adult | 2012 |
Assessing the cumulative effects of exposure to selected benzodiazepines on the risk of fall-related injuries in the elderly.
Topics: Accidental Falls; Aged; Alprazolam; Benzodiazepines; Bromazepam; Chlordiazepoxide; Clonazepam; Female; Flurazepam; Humans; Lorazepam; Male; Proportional Hazards Models; Risk Factors; Temazepam | 2012 |
How often do false-positive phencyclidine urine screens occur with use of common medications?
Topics: Alprazolam; Carbazoles; Carvedilol; Clonazepam; Dextromethorphan; Diphenhydramine; Drug Interactions; False Positive Reactions; Gas Chromatography-Mass Spectrometry; Humans; Phencyclidine; Propanolamines; Retrospective Studies; Substance-Related Disorders; Tramadol | 2013 |
Dependence of the kinetic and thermodynamic parameters on hydrophilic-lipophilic character of alprazolam, clonazepam, diazepam, doxepin and haloperidol in alkaline environment.
Topics: Alprazolam; Clonazepam; Diazepam; Doxepin; Drug Stability; Haloperidol; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kinetics; Thermodynamics | 2013 |
Detection Times of Diazepam, Clonazepam, and Alprazolam in Oral Fluid Collected From Patients Admitted to Detoxification, After High and Repeated Drug Intake.
Topics: Adult; Alprazolam; Chromatography, High Pressure Liquid; Clonazepam; Diazepam; Female; Humans; Male; Middle Aged; Saliva; Substance Abuse Detection; Substance-Related Disorders; Tandem Mass Spectrometry; Time Factors; Young Adult | 2015 |
Development of an ultra-high-performance liquid chromatography coupled to high-resolution quadrupole-Orbitrap mass spectrometry method for the rapid detection and confirmation of illegal adulterated sedative-hypnotics in dietary supplements.
Topics: Alprazolam; Chromatography, High Pressure Liquid; Clonazepam; Diazepam; Dietary Supplements; Drug Contamination; Food Safety; Humans; Hypnotics and Sedatives; Limit of Detection; Reproducibility of Results; Tandem Mass Spectrometry | 2015 |
Clinically applicable GABA receptor positive allosteric modulators promote ß-cell replication.
Topics: Allosteric Regulation; Alprazolam; Animals; Benzodiazepines; Carrier Proteins; Cell Division; Cell Proliferation; Clonazepam; GABA Modulators; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Humans; Insulin-Secreting Cells; Islets of Langerhans; Mice; Midazolam; Rats; Receptors, GABA-A | 2017 |
Toxicological findings in 1000 cases of suspected drug facilitated sexual assault in the United States.
Topics: Adolescent; Adult; Age Distribution; Alprazolam; Benzodiazepines; Cannabinoids; Central Nervous System Depressants; Child; Child, Preschool; Clonazepam; Crime Victims; Ethanol; Female; Forensic Toxicology; Humans; Hypnotics and Sedatives; Illicit Drugs; Infant; Male; Middle Aged; Poisoning; Sex Distribution; Sex Offenses; Sodium Oxybate; United States; Young Adult | 2019 |
LC-MS-MS Method for the Determination of Antidepressants and Benzodiazepines in Meconium.
Topics: Alprazolam; Antidepressive Agents; Benzodiazepines; Chromatography, Liquid; Clonazepam; Forensic Toxicology; Humans; Limit of Detection; Meconium; Nordazepam; Oxazepam; Reproducibility of Results; Solid Phase Extraction; Substance Abuse Detection; Tandem Mass Spectrometry; Venlafaxine Hydrochloride; Zolpidem | 2020 |
Postmortem Analysis of Benzodiazepines in Human Bone by Gas Chromatography-Mass Spectrometry.
Topics: Alprazolam; Autopsy; Benzodiazepines; Chromatography, Liquid; Clonazepam; Diazepam; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Liquid-Liquid Extraction; Lorazepam; Nordazepam; Oxazepam; Tandem Mass Spectrometry | 2021 |
Rapid Extraction and Qualitative Screening of 30 Drugs in Oral Fluid at Concentrations Recommended for the Investigation of DUID Cases.
Topics: 2-Propanol; 3,4-Methylenedioxyamphetamine; Alprazolam; Amphetamines; Buprenorphine; Carisoprodol; Clonazepam; Cocaine; Codeine; Dronabinol; Fentanyl; Hexanes; Hydrocodone; Hydromorphone; Lorazepam; Meprobamate; Methadone; Methamphetamine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Nordazepam; Oxazepam; Oxycodone; Oxymorphone; Pharmaceutical Preparations; Phencyclidine; Tandem Mass Spectrometry; Temazepam; Tramadol; Zolpidem | 2022 |
Population-based screening to detect benzodiazepine drug-drug-drug interaction signals associated with unintentional traumatic injury.
Topics: Accidental Injuries; Alprazolam; Atorvastatin; Bayes Theorem; Benzodiazepines; Cefuroxime; Clonazepam; Drug Interactions; Humans; Hydrocodone | 2022 |
Occurrence of Z-drugs, benzodiazepines, and ketamine in wastewater in the United States and Mexico during the Covid-19 pandemic.
Topics: Alprazolam; Benzodiazepines; Clonazepam; COVID-19; Diazepam; Humans; Ketamine; Lorazepam; Mexico; Nordazepam; Pandemics; Tandem Mass Spectrometry; Temazepam; United States; Wastewater; Zolpidem | 2023 |
Validation of an HPLC-HR-MS Method for the Determination and Quantification of Six Drugs (Morphine, Codeine, Methadone, Alprazolam, Clonazepam and Quetiapine) in Nails.
Topics: Alprazolam; Benzodiazepines; Chromatography, High Pressure Liquid; Clonazepam; Codeine; Humans; Methadone; Morphine; Nails; Quetiapine Fumarate | 2023 |